GM-CSF: A double dose of protection during pneumonia

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 302, Issue 5, 2012, Pages

  Quinton, Lee J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; I KAPPA B; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 4;

APOPTOSIS; CELL DEATH; CELL SURVIVAL; CYTOKINE PRODUCTION; EDITORIAL; GENE DELETION; GENE EXPRESSION; GRAM NEGATIVE BACTERIUM; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LOWER RESPIRATORY TRACT; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY FUNCTION; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ACUTE LUNG INJURY; ANIMALS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; PNEUMONIA, BACTERIAL; TOLL-LIKE RECEPTOR 4;

EID: 84857749127     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00022.2012     Document Type: Editorial

References (16)

1. Ballinger MN, Paine R 3rd, Serezani CH, Aronoff DM, Choi ES, Standiford TJ, Toews GB, Moore BB. Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa. Am J Respir Cell Mol Biol 34: 766-774, 2006.
2. Beck JM, Preston AM, Wilcoxen SE, Morris SB, Sturrock A, Paine R 3rd. Critical roles of inflammation and apoptosis in improved survival in a model of hyperoxia-induced acute lung injury in Pneumocystis murinainfected mice. Infect Immun 77: 1053-1060, 2009.
3. Bozinovski S, Jones J, Beavitt SJ, Cook AD, Hamilton JA, Anderson GP. Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4. Am J Physiol Lung Cell Mol Physiol 286: L877-L885, 2004.
4. Cakarova L, Marsh LM, Wilhelm J, Mayer K, Grimminger F, Seeger W, Lohmeyer J, Herold S. Macrophage tumor necrosis factor-α induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair. Am J Respir Crit Care Med 180: 521-532, 2009.
5. Huang FF, Barnes PF, Feng Y, Donis R, Chroneos ZC, Idell S, Allen T, Perez DR, Whitsett JA, Dunussi-Joannopoulos K, Shams H. GMCSF in the lung protects against lethal influenza infection. Am J Respir Crit Care Med 184: 259-268, 2011.
6. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, Medzhitov R, Noble PW. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11: 1173-1179, 2005.
7. Matute-Bello G, Liles WC, Radella F 2nd, Steinberg KP, Ruzinski JT, Hudson LD, Martin TR. Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colonystimulating factor during the course of acute respiratory distress syndrome. Crit Care Med 28: 1-7, 2000.
8. Mizgerd JP. Acute lower respiratory tract infection. N Engl J Med 358: 716-727, 2008.
9. Paine R 3rd, Standiford TJ, Dechert RE, Moss M, Martin GS, Rosenberg AL, Thannickal VJ, Burnham EL, Brown MB, Hyzy RC. A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury*. Crit Care Med 40: 90-97, 2012.
10. Paine R 3rd, Wilcoxen SE, Morris SB, Sartori C, Baleeiro CE, Matthay MA, Christensen PJ. Transgenic overexpression of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxic lung injury. Am J Pathol 163: 2397-2406, 2003.
11. Presneill JJ, Harris T, Stewart AG, Cade JF, Wilson JW. A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Am J Respir Crit Care Med 166: 138-143, 2002.
12. Quinton LJ, Mizgerd JP. NF-κB and STAT3 signaling hubs for lung innate immunity. Cell Tissue Res 343: 153-165, 2011.
13. Standiford LR, Standiford TJ, Newstead MJ, Zeng X, Ballinger MN, Kovach MA, Reka AK, Bhan U. TLR4-dependent GM-CSF protects against lung injury in gram-negative bacterial pneumonia. Am J Physiol Lung Cell Mol Physiol. First published December 9, 2011; doi:10.1152/ajplung.00415.2010.
14. Steinwede K, Tempelhof O, Bolte K, Maus R, Bohling J, Ueberberg B, Langer F, Christman JW, Paton JC, Ask K, Maharaj S, Kolb M, Gauldie J, Welte T, Maus UA. Local delivery of GM-CSF protects mice from lethal pneumococcal pneumonia. J Immunol 187: 5346-5356, 2011.
15. Trapnell BC, Carey BC, Uchida K, Suzuki T. Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages. Curr Opin Immunol 21: 514-521, 2009.
16. Zhang X, Shan P, Qureshi S, Homer R, Medzhitov R, Noble PW, Lee PJ. Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. J Immunol 175: 4834-4838, 2005.